Stock Events

Microbot Medical 

$0.9
26
-$0.05-5.14% Wednesday 20:00

Statistics

Day High
0.95
Day Low
0.88
52W High
3.66
52W Low
0.88
Volume
237,867
Avg. Volume
105,501
Mkt Cap
12.96M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

15MayExpected
Q2 2022
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Next
-0.51
-0.4
-0.3
-0.19
Expected EPS
-0.19
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MBOT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap136.39B
Intuitive Surgical is a leading developer of robotic-assisted surgical systems, directly competing with Microbot Medical's robotic technologies aimed at improving clinical outcomes.
Medtronic
MDT
Mkt Cap106.4B
Medtronic offers robotic-assisted surgery solutions, competing in the same space as Microbot Medical with its innovative medical devices for minimally invasive procedures.
Smith & Nephew
SNN
Mkt Cap10.39B
Smith & Nephew provides advanced surgical robotics for orthopedic procedures, competing with Microbot Medical in the broader field of robotic-assisted surgeries.
Zimmer Biomet
ZBH
Mkt Cap25.58B
Zimmer Biomet Holdings, Inc. competes in the development of robotic solutions for orthopedic surgeries, a market that overlaps with Microbot Medical's target for their robotic devices.
Stryker
SYK
Mkt Cap130.14B
Stryker Corporation specializes in medical technologies, including robotic surgery systems, making it a competitor in the robotic-assisted surgical market alongside Microbot Medical.
Johnson & Johnson
JNJ
Mkt Cap355.49B
Johnson & Johnson, through its subsidiary Ethicon, is involved in the development of surgical robotics, competing with Microbot Medical's innovations in the same domain.
Boston Scientific
BSX
Mkt Cap99.87B
Boston Scientific Corporation offers products that compete in the minimally invasive medical device market, including endoscopy and interventional cardiology, areas where Microbot Medical also aims to innovate.
Abbvie
ABBV
Mkt Cap287.34B
AbbVie, while primarily known for its pharmaceuticals, has ventured into medical devices and robotics through acquisitions, indirectly competing with Microbot Medical's focus on robotic surgical solutions.
Alphabet
GOOGL
Mkt Cap1.99T
Alphabet Inc., through its Verily life sciences division, is exploring robotic surgery and other medical technologies, making it a potential future competitor in the innovative medical robotics space where Microbot Medical operates.

Analyst Ratings

7$Average Price Target
The highest estimate is $7.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

About

Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.
Show more...
CEO
Harel Gadot
Employees
21
Country
US
ISIN
US59503A2042
WKN
000A2N5AS

Listings